NuclixBio
@nuclixbio.com
Developing Innovative Nucleic Acid Therapeutics
NuclixBio's Company Logos
NuclixBio's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#1A73E8
Royal Blue
26, 115, 232
214, 82, 51
89, 50, 0, 9
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#202124
Shark
32, 33, 36
225, 6, 13
11, 8, 0, 86
About NuclixBio
NuclixBio is a pioneering brand that focuses on the early-stage research and development of intracellularly targeted nucleic acid therapeutics. With an unwavering dedication to "Drugging the Undruggable," NuclixBio utilizes its proprietary platform technologies to create next-generation targeted therapeutics.
Their innovative Circular mRNA platform and Aptamer-Drug Conjugates set NuclixBio apart as leaders in the field. These cutting-edge technologies pave the way for the treatment of previously "Undruggable" targets, opening new possibilities in the medical world.
Composed of a team of nucleic acid engineering experts, NuclixBio is always open to collaborations and partnerships for further advancements. They welcome questions and ideas, encouraging a cooperative approach to revolutionizing medicine.
Based in Seoul, Republic of Korea, NuclixBio's headquarters can be found at 801, Digital-ro 33-gil 28, Guro-gu. For inquiries, you can reach them at +82-2-6951-5893 or via email at [email protected].
Experience the future of targeted therapeutics with NuclixBio, where groundbreaking science meets innovative solutions. Copyright © 2021 NuclixBio. All rights reserved.
Company type
Privately Held
Year founded
2017
Company size
11-50 employees
